Semiparametric Mixed Model for Evaluating Pathway-Environment Interaction
Zaili Fang, Inyoung Kim, Jeesun Jung

TL;DR
This paper introduces a semiparametric mixed model combining kernel machines and splines to evaluate pathway-environment interactions, successfully identifying significant pathways and interactions in Type II diabetes data.
Contribution
It develops a novel semiparametric approach for pathway-environment interaction analysis, integrating kernel methods with mixed effects models for improved detection.
Findings
Identified pathways with significant main effects and interactions.
Detected novel pathway-environment interactions in diabetes data.
Outperformed existing methods in identifying interaction effects.
Abstract
A biological pathway represents a set of genes that serves a particular cellular or a physiological function. The genes within the same pathway are expected to function together and hence may interact with each other. It is also known that many genes, and so pathways, interact with other environmental variables. However, no formal procedure has yet been developed to evaluate the pathway-environment interaction. In this article, we propose a semiparametric method to model the pathway-environment interaction. The method connects a least square kernel machine and a semiparametric mixed effects model. We model nonparametrically the environmental effect via a natural cubic spline. Both a pathway effect and an interaction between a pathway and an environmental effect are modeled nonparametrically via a kernel machine, and we estimate variance component representing an interaction effect under…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBioinformatics and Genomic Networks · Computational Drug Discovery Methods · Statistical Methods in Clinical Trials
